Concepts (128)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Nerve Block | 3 | 2019 | 183 | 1.30 | Why? |
| Ventilator-Induced Lung Injury | 5 | 2019 | 260 | 0.96 | Why? |
| Anesthetics, Local | 2 | 2019 | 205 | 0.73 | Why? |
| Thumb | 1 | 2017 | 42 | 0.71 | Why? |
| Injections | 1 | 2018 | 237 | 0.67 | Why? |
| Catheterization, Peripheral | 1 | 2017 | 249 | 0.54 | Why? |
| Paraspinal Muscles | 3 | 2019 | 45 | 0.41 | Why? |
| Ischemia | 1 | 2017 | 901 | 0.39 | Why? |
| Ventilators, Mechanical | 2 | 2020 | 2193 | 0.36 | Why? |
| Positive-Pressure Respiration | 4 | 2019 | 1160 | 0.32 | Why? |
| Respiration, Artificial | 9 | 2021 | 22116 | 0.30 | Why? |
| Supine Position | 1 | 2021 | 158 | 0.21 | Why? |
| Extracorporeal Membrane Oxygenation | 5 | 2019 | 5002 | 0.21 | Why? |
| Intubation | 1 | 2021 | 437 | 0.19 | Why? |
| Esophagectomy | 1 | 2018 | 76 | 0.18 | Why? |
| Radial Artery | 1 | 2017 | 132 | 0.16 | Why? |
| Pulmonary Aspergillosis | 1 | 2021 | 408 | 0.16 | Why? |
| Respiratory Insufficiency | 4 | 2021 | 7301 | 0.15 | Why? |
| Analgesia | 1 | 2018 | 211 | 0.15 | Why? |
| Carbon Dioxide | 2 | 2019 | 917 | 0.15 | Why? |
| Dysbiosis | 1 | 2021 | 685 | 0.14 | Why? |
| Tidal Volume | 4 | 2019 | 565 | 0.14 | Why? |
| Pain, Postoperative | 1 | 2018 | 289 | 0.14 | Why? |
| Invasive Pulmonary Aspergillosis | 1 | 2021 | 634 | 0.14 | Why? |
| Platelet Count | 1 | 2018 | 1381 | 0.11 | Why? |
| Patient Positioning | 1 | 2021 | 1505 | 0.10 | Why? |
| Bacteria | 1 | 2021 | 1897 | 0.10 | Why? |
| Prone Position | 1 | 2021 | 1861 | 0.10 | Why? |
| Survivors | 1 | 2021 | 2619 | 0.09 | Why? |
| Dose-Response Relationship, Drug | 1 | 2018 | 3776 | 0.09 | Why? |
| Logistic Models | 2 | 2020 | 9089 | 0.09 | Why? |
| Lung | 5 | 2021 | 31049 | 0.09 | Why? |
| Interferons | 1 | 2020 | 2885 | 0.09 | Why? |
| Noninvasive Ventilation | 1 | 2021 | 2329 | 0.09 | Why? |
| Oxygen Inhalation Therapy | 1 | 2021 | 3629 | 0.08 | Why? |
| Body Mass Index | 1 | 2020 | 4306 | 0.08 | Why? |
| Critical Illness | 5 | 2021 | 17281 | 0.08 | Why? |
| Critical Care | 2 | 2021 | 14081 | 0.07 | Why? |
| Intubation, Intratracheal | 1 | 2021 | 3962 | 0.07 | Why? |
| Patient Discharge | 1 | 2021 | 5696 | 0.07 | Why? |
| Dyspnea | 1 | 2018 | 3847 | 0.07 | Why? |
| Sepsis | 2 | 2021 | 3517 | 0.07 | Why? |
| Humans | 27 | 2021 | 930598 | 0.07 | Why? |
| Adrenal Cortex Hormones | 1 | 2020 | 6537 | 0.06 | Why? |
| Respiratory Mechanics | 2 | 2017 | 585 | 0.06 | Why? |
| Forecasting | 1 | 2017 | 4492 | 0.06 | Why? |
| Aged | 15 | 2021 | 215776 | 0.06 | Why? |
| Italy | 6 | 2021 | 38444 | 0.06 | Why? |
| Pulmonary Embolism | 1 | 2020 | 4775 | 0.05 | Why? |
| Quality of Life | 1 | 2021 | 9820 | 0.05 | Why? |
| Swine | 2 | 2019 | 3352 | 0.05 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.05 | Why? |
| Middle Aged | 14 | 2021 | 270681 | 0.05 | Why? |
| Obesity | 1 | 2020 | 7388 | 0.05 | Why? |
| Anticoagulants | 1 | 2020 | 9563 | 0.05 | Why? |
| Partial Pressure | 1 | 2019 | 279 | 0.05 | Why? |
| Cross Infection | 1 | 2021 | 8675 | 0.05 | Why? |
| Catheters | 1 | 2018 | 93 | 0.05 | Why? |
| Male | 15 | 2021 | 367725 | 0.04 | Why? |
| Interferon beta-1a | 1 | 2020 | 316 | 0.04 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.04 | Why? |
| Tomography, X-Ray Computed | 3 | 2020 | 25144 | 0.04 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.04 | Why? |
| Lung Volume Measurements | 1 | 2017 | 115 | 0.04 | Why? |
| Barotrauma | 1 | 2017 | 97 | 0.04 | Why? |
| Female | 13 | 2021 | 380317 | 0.04 | Why? |
| Pressure | 1 | 2017 | 289 | 0.04 | Why? |
| Albumins | 1 | 2018 | 324 | 0.04 | Why? |
| Lung Compliance | 1 | 2017 | 243 | 0.04 | Why? |
| Models, Animal | 1 | 2019 | 788 | 0.04 | Why? |
| Survival Analysis | 2 | 2020 | 7592 | 0.04 | Why? |
| Respiratory Rate | 1 | 2019 | 691 | 0.04 | Why? |
| Treatment Failure | 1 | 2021 | 2106 | 0.04 | Why? |
| Prospective Studies | 4 | 2021 | 43301 | 0.04 | Why? |
| Retrospective Studies | 6 | 2021 | 105322 | 0.03 | Why? |
| Fibrin Fibrinogen Degradation Products | 2 | 2020 | 5993 | 0.03 | Why? |
| Germany | 2 | 2020 | 9196 | 0.03 | Why? |
| Chile | 1 | 2018 | 1095 | 0.03 | Why? |
| Catheterization, Central Venous | 1 | 2019 | 458 | 0.03 | Why? |
| Ventilator Weaning | 1 | 2019 | 536 | 0.03 | Why? |
| Pneumonia, Ventilator-Associated | 1 | 2021 | 861 | 0.03 | Why? |
| Fibrinolysis | 1 | 2018 | 521 | 0.03 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2021 | 2309 | 0.03 | Why? |
| Ferritins | 1 | 2020 | 2055 | 0.03 | Why? |
| Heparin, Low-Molecular-Weight | 1 | 2020 | 1731 | 0.03 | Why? |
| Microbiota | 1 | 2021 | 1240 | 0.03 | Why? |
| Antiviral Agents | 2 | 2020 | 41703 | 0.03 | Why? |
| Computed Tomography Angiography | 1 | 2020 | 2153 | 0.03 | Why? |
| Intensive Care Units | 3 | 2021 | 29594 | 0.03 | Why? |
| Adult | 7 | 2021 | 244371 | 0.03 | Why? |
| Multivariate Analysis | 1 | 2020 | 5440 | 0.02 | Why? |
| Odds Ratio | 1 | 2020 | 5861 | 0.02 | Why? |
| Equipment Design | 1 | 2019 | 3095 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2020 | 6543 | 0.02 | Why? |
| Severity of Illness Index | 3 | 2021 | 48226 | 0.02 | Why? |
| Risk Factors | 3 | 2020 | 71621 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2020 | 7268 | 0.02 | Why? |
| Hydroxychloroquine | 2 | 2020 | 12447 | 0.02 | Why? |
| Hospital Mortality | 2 | 2021 | 22087 | 0.02 | Why? |
| Risk Assessment | 2 | 2020 | 25439 | 0.02 | Why? |
| Hypoxia | 1 | 2021 | 3626 | 0.02 | Why? |
| Lopinavir | 1 | 2020 | 4308 | 0.02 | Why? |
| Ritonavir | 1 | 2020 | 4212 | 0.02 | Why? |
| Hospitalization | 3 | 2020 | 54280 | 0.02 | Why? |
| Thrombocytopenia | 1 | 2018 | 2093 | 0.02 | Why? |
| France | 1 | 2020 | 12074 | 0.02 | Why? |
| Aged, 80 and over | 3 | 2020 | 88759 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2020 | 11304 | 0.02 | Why? |
| Length of Stay | 1 | 2020 | 11042 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2021 | 17020 | 0.01 | Why? |
| Interleukin-6 | 1 | 2020 | 7522 | 0.01 | Why? |
| Disease Progression | 1 | 2020 | 13580 | 0.01 | Why? |
| Hospitals | 1 | 2020 | 11793 | 0.01 | Why? |
| Disease Models, Animal | 1 | 2019 | 10998 | 0.01 | Why? |
| Pandemics | 4 | 2020 | 389249 | 0.01 | Why? |
| Viral Load | 1 | 2020 | 15850 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2020 | 22971 | 0.01 | Why? |
| Animals | 2 | 2019 | 78931 | 0.01 | Why? |
| Cohort Studies | 1 | 2021 | 36005 | 0.01 | Why? |
| Prognosis | 1 | 2020 | 32490 | 0.01 | Why? |
| Practice Guidelines as Topic | 1 | 2021 | 15421 | 0.01 | Why? |
| Child, Preschool | 1 | 2020 | 36283 | 0.01 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.01 | Why? |
| Biomarkers | 1 | 2018 | 23361 | 0.01 | Why? |
| Treatment Outcome | 1 | 2020 | 51732 | 0.01 | Why? |
| Child | 1 | 2020 | 70012 | 0.01 | Why? |
| Adolescent | 1 | 2020 | 86841 | 0.01 | Why? |
| Young Adult | 1 | 2020 | 93724 | 0.01 | Why? |
Tonetti's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(128)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(256)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_